Literature DB >> 19608159

Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.

Keon Hee Yoo1, In Keun Jang, Myoung Woo Lee, Hyo Eun Kim, Mal Sook Yang, Youngwoo Eom, Jong Eun Lee, Young Jin Kim, Seong Kyu Yang, Hye Lim Jung, Ki Woong Sung, Cheol Woo Kim, Hong Hoe Koo.   

Abstract

Mesenchymal stem cells (MSCs), which evoke only minimal immune reactivity, may have anti-inflammatory and immunomodulatory effects. In this study, we conducted a comparative analysis of the immunomodulatory properties of MSCs derived from adult human tissues including bone marrow (BM), adipose tissues (AT), umbilical cord blood (CB), and cord Wharton's jelly (WJ). Using a multiple cytokine detection assay, we showed that there were no significant differences in levels of secreted factors from non-stimulated MSCs. We compared the immunosuppressive effect of BM-MSCs, AT-MSCs, CB-MSCs, and WJ-MSCs on phytohemagglutinin-induced T-cell proliferation. AT-MSCs, CB-MSCs, and WJ-MSCs effectively suppressed mitogen-induced T-cell proliferation as effectively as did BM-MSCs. Levels of interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha secreted from activated T-cells increased over time, but these levels were significantly reduced when cocultured with each type of MSCs. In addition, the expression of hepatocyte growth factor, IL-10, transforming growth factor-beta(1), cyclooxygenase (COX)-1, and COX-2 were unchanged in MSCs treated with IFN-gamma and/or TNF-alpha, while indoleamine 2,3-dioxygenase (IDO) expression increased. IFN-gamma and/or TNF-alpha produced by activated T-cells were correlated with induction of IDO expression by MSCs, which, in turn, suppressed T-cell proliferation. These findings suggest that MSCs derived from AT, CB, or WJ could be substituted for BM-MSCs for treatment of allogeneic conflicts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608159     DOI: 10.1016/j.cellimm.2009.06.010

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  141 in total

1.  Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate.

Authors:  A Poloni; G Maurizi; F Serrani; S Mancini; G Discepoli; A L Tranquilli; R Bencivenga; P Leoni
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

Review 2.  Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Authors:  Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo Giannuzzi; Felicia Farina; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

3.  Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue.

Authors:  Naghmeh Ahmadian Kia; Ahmad Reza Bahrami; Marzieh Ebrahimi; Maryam M Matin; Zeinab Neshati; Mahmood Rais Almohaddesin; Naser Aghdami; Hamid Reza Bidkhori
Journal:  J Mol Neurosci       Date:  2010-10-12       Impact factor: 3.444

Review 4.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

5.  Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.

Authors:  Sara M Melief; Jaap Jan Zwaginga; Willem E Fibbe; Helene Roelofs
Journal:  Stem Cells Transl Med       Date:  2013-05-21       Impact factor: 6.940

6.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

7.  Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).

Authors:  O Parolini; F Alviano; A G Betz; D W Bianchi; C Götherström; U Manuelpillai; A L Mellor; R Ofir; P Ponsaerts; S A Scherjon; M L Weiss; S Wolbank; K J Wood; C V Borlongan
Journal:  Placenta       Date:  2011-05-14       Impact factor: 3.481

Review 8.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

9.  TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia.

Authors:  Megan L Kelly; Meijing Wang; Paul R Crisostomo; Aaron M Abarbanell; Jeremy L Herrmann; Brent R Weil; Daniel R Meldrum
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

10.  Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.

Authors:  S Jyothi Prasanna; Divya Gopalakrishnan; Shilpa Rani Shankar; Anoop Babu Vasandan
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.